Outcomes may improve with disease-modifying drugs and lifestyle change if Alzheimer's could be identified earlier.

Frontotemporal dementia can be hard to diagnose because while dementia can be part of the illness, it's not a factor in all ...

Longview residents were out in front of the Gregg County Courthouse on Saturday to take part in the Walk to End Alzheimer's ...

The brain has a waste-disposal system that clears away junk proteins that contribute to the development of dementia and ...

Sage has decided to discontinue the development of dalzanemdor in Alzheimer’s disease. A study of the candidate in Huntington ...

Sage Therapeutics has seen another clinical trial go up in smoke. | Sage Therapeutics has seen another clinical trial go up ...

After a series of setbacks for dalzanemdor, some analysts now expect that Sage won’t reach profitability for awhile — and only if its cost structure undergoes significant changes.

Saturday marked the 16th year for the Walk to End Alzheimer’s here in Victoria, however, the fight for the disease has been ...

Researchers in China reported finding β-amyloid (Aβ) deposits along the ocular glymphatic system in patients with Alzheimer's ...

Sage Therapeutics does not plan further clinical development of its dalzanemdor drug candidate in Alzheimer's disease following its failure in a mid-stage study.

Muscae volitantes — “eye floaters” are those little, transparent threads that you see floating across your eyeball. Generally ...